<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03352570</url>
  </required_header>
  <id_info>
    <org_study_id>SAFE-1</org_study_id>
    <nct_id>NCT03352570</nct_id>
  </id_info>
  <brief_title>a Study to Investigate the Efficacy, and Safety of the Colovac Colorectal Anastomosis Protection Device.</brief_title>
  <acronym>SAFE-1</acronym>
  <official_title>Safe (Safe Anastomosis Feasibility Evaluation)-1 Study : a Study to Investigate the Efficacy, Mechanism of Action and Safety of the Colovac Colorectal Anastomosis Protection Device First-In-man Clinical Investigation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Safeheal</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Safeheal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate theColovac device, a single use, temporary
      intraluminal bypass device,intended to reduce contact of fecal content with an anastomotic
      site, following colorectal surgery (open or laparoscopic).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2017</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of adverse events</measure>
    <time_frame>up to 3 months</time_frame>
    <description>occurence of intraoperative and postoperative complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>device introduction success rate</measure>
    <time_frame>During surgery</time_frame>
    <description>Ability to introduce, deploy and retrieve the Colovac Anastomosis Protection Device in/from the desired location in the colon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device placement success rate</measure>
    <time_frame>During surgery</time_frame>
    <description>Measured by number of successful placement divided by overall placement number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colovac procedure time</measure>
    <time_frame>During surgery</time_frame>
    <description>Procedure duration measured in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Migration rate of the Colovac device</measure>
    <time_frame>During surgical procedure and up to 15 days after placement</time_frame>
    <description>defined by the number of devices migrated over the anastomosis divided by the number of devices placed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device retrieval success rate</measure>
    <time_frame>At 14 days after device placement</time_frame>
    <description>Retrieval success rate measured by number of successful retrieval without complication divided by overall number of retrieval performed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of digestive disorders</measure>
    <time_frame>up to 15 days after surgery</time_frame>
    <description>Measured as number of patients presenting digestive disorders divided by overall number of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of patient comfort measured using NIH's PROMIS health measurement questionnaires</measure>
    <time_frame>up to 15 days after surgery</time_frame>
    <description>measures using health measurement questionnaires to assess parameters like pain (visual analogue scale - 1 : no pain - 10 : worse pain ever); bowel incontinence (visual analogue scale - 1 : no incontinence - 10 : uncontrollable incontinence), diarrhea (visual analogue scale - 1 : no pain - 10 : worse pain ever); bowel incontinence (visual analogue scale - 1 : no diarrhea - 10 : more than 3 episodes of diarrhea per day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurence of anastomosis leakage</measure>
    <time_frame>up to 3 months after initial surgery</time_frame>
    <description>measured as mean number of anastomosis leakage episodes per patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of anastomosis fistula</measure>
    <time_frame>up to 3 months after initial surgery</time_frame>
    <description>measured as mean number of anastomosis fisutal episodes per patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of anastomotic abcesses</measure>
    <time_frame>up to 3 months after initial surgery</time_frame>
    <description>measured as mean number of anastomosis abcess episodes per patient</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Gastrointestinal Anastomotic Complication</condition>
  <arm_group>
    <arm_group_label>COLOVAC device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>colorectal surgery performed per standard of care with deployment of the Colovac device to protect the anastomosis site</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>COLOVAC</intervention_name>
    <description>The intervention consists in the placement of the Colovac device, during the colorectal surgery, Once the colorectal anastomosis has been completed as per standard care and the water-thightness of the anastomosis has been verified.</description>
    <arm_group_label>COLOVAC device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject must be &gt;= 18 and &lt;= 65 years old

          2. Indicated for colorectal resection

          3. Patient has been assessed by a multi-disciplinary team and it was determined that as
             per standard of care, they are eligible to bear a diverting ostomy

          4. Willing to comply with protocol-specified follow-up evaluations

          5. Signed Informed Consent

        Exclusion Criteria:

          1. Patient with inflammatory bowel disease

          2. Pregnant or nursing female subject (a pregnancy test should be conducted the day prior
             to the procedure for all women in age of procreating)

          3. Known allergy to nickel or other components of the Colovac kit

          4. Any significant medical condition which, in the investigator's opinion, may interfere
             with the subject's optimal participation in the study, including:

               1. immunodeficiency

               2. steroid therapy

               3. infections at the time of intervention

               4. major surgical or interventional procedures within 30 days prior to this study or
                  planned surgical or interventional procedures within 30 days of entry into this
                  study

               5. diagnosis of bowel obstruction, bowel strangulation, peritonitis, bowel
                  perforation, local or systemic infection, ischemic bowel, carcinomatosis

               6. preexisting sphincter problems or evidence of extensive local disease in the
                  pelvis

               7. blood loss (&gt; 500 cc)

               8. non amended peroperative anastomosis failure

               9. intra-operative adverse events

              10. malnourishment

              11. obesity (BMI &gt; 35)

              12. history of excessive smoking and alcohol use

          5. The subject is currently participating in another investigational drug or device study
             that has not completed the primary endpoint or that clinically interferes with the
             endpoints of this study

          6. Patient unable to give consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cécile Dupont</last_name>
    <phone>0033783223446</phone>
    <email>Cecile@safehealmedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karl BLOHM</last_name>
    <email>Karl@safehealmedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Saint-Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hakeem Admane</last_name>
      <phone>0033171970558</phone>
      <email>farid-hakeem.admane@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Hakeem Admane</last_name>
    </contact_backup>
    <investigator>
      <last_name>Jérémie Lefevre, phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ihu Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Pernot</last_name>
      <phone>0033390413631</phone>
      <email>sophie.pernot@ihu-strasbourg.eu</email>
    </contact>
    <investigator>
      <last_name>Dr. d'urso, md</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2017</study_first_submitted>
  <study_first_submitted_qc>November 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2017</study_first_posted>
  <last_update_submitted>December 19, 2017</last_update_submitted>
  <last_update_submitted_qc>December 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anastomotic leakage</keyword>
  <keyword>fistula</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

